-
Federal
LactMed (Drugs and Lactation Database)
U.S. Department of Health & Human Services —
LactMed (Drugs and Lactation Database) contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the... -
Federal
Cancer Incidence - Surveillance, Epidemiology, and End Results (SEER) Registries Limited-Use
U.S. Department of Health & Human Services —
SEER Limited-Use cancer incidence data with associated population data. Geographic areas available are county and SEER registry. The Surveillance, Epidemiology, and... -
Federal
Computational Photography Project for Pill Identification (C3PI)
U.S. Department of Health & Human Services —
The Computational Photography Project for Pill Identification (C3PI) was sunset in 2018. No new images will be added to the collection. Identifiers for pills will not... -
Federal
Unified Medical Language System (UMLS)
U.S. Department of Health & Human Services —
The UMLS integrates and distributes key terminology, classification and coding standards, and associated resources to promote creation of more effective and... -
Federal
Hazardous Substances Data Bank (HSDB)
U.S. Department of Health & Human Services —
Hazardous Substances Data Bank (HSDB) was a toxicology database that focused on the toxicology of potentially hazardous chemicals. It provided information on human... -
Federal
Carcinogenic Potency Database (CPDB)
U.S. Department of Health & Human Services —
Carcinogenic Potency Database (CPDB) is a single standardized resource of the results of 45 years of chronic, long-term carcinogenesis bioassays. The experiments vary... -
Federal
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)—Wave 1 (2001–2002), and Wave 2 (2004–2005)
U.S. Department of Health & Human Services —
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) was designed to assess the prevalence of alcohol use disorders (AUD) and their associated... -
Federal
NIH Data Sharing Repositories
U.S. Department of Health & Human Services —
A list of NIH-supported repositories that accept submissions of appropriate scientific research data from biomedical researchers. It includes resources that aggregate... -
Federal
Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports
U.S. Department of Health & Human Services —
Background This investigation was undertaken to describe patient perception and awareness of the polycystic ovary syndrome (PCOS), the most common cause of... -
Federal
Substance 864567: MLS000083815
U.S. Department of Health & Human Services —
Chemical substance data from PubChem database. This dataset contains comprehensive chemical information including structural data, physical properties, and biological... -
Federal
Compound 530394: N-(2-Methylpropyl)-2,6,8-decatrienamide
U.S. Department of Health & Human Services —
Chemical compound data from PubChem database. IUPAC Name: N-(2-methylpropyl)deca-2,6,8-trienamide. Molecular Formula: C14H23NO. Molecular Weight: 221.34. This dataset... -
Federal
LocatorPlus
U.S. Department of Health & Human Services —
A MARC-based catalog, the LocatorPlus Catalog provides access to NLM bibliographic data for journals, books, audiovisuals, computer software, electronic resources and... -
Federal
NLM Digital Collections
U.S. Department of Health & Human Services —
The National Library of Medicine's (NLM) Digital Collections offers a search-based Web service that provides access to the Dublin Core metadata and full-text OCR of... -
Federal
MEDLINE/PubMed Baseline Statistics: Misc Report
U.S. Department of Health & Human Services —
A file containing all Misc Baseline Reports for 2018-2023 in their original format is available in the Attachments section below. MEDLINE/PubMed annual statistical... -
Federal
The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia
U.S. Department of Health & Human Services —
Background Finasteride, a 5 alpha reductase inhibitor, is an established treatment for benign prostatic hyperplasia. The recommended dosage is 5 mg a day, however... -
Federal
Determinants of abstract acceptance for the Digestive Diseases Week – a cross sectional study
U.S. Department of Health & Human Services —
Background The Digestive Diseases Week (DDW) is the major meeting for presentation of research in gastroenterology. The acceptance of an abstract for presentation at...